Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.

Journal of Korean medical science - 1 Oct 2001

Lee K W, Lee J M, Jung K S

Abstract excerpt

Pyrazinamide (PZA) is one of the most important drugs for the treatment of Mycobacterium tuberculosis infection. However, the increasing frequency of PZA-resistant strains limits its effectiveness. In Korea, most PZA-resistant strains also exhibit both isoniazid and rifampin resistance making it essential to identify these resistant strains accurately and rapidly for effective treatment of mycobacterial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amidohydrolases
Share to Antitubercular Agents
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Mycobacterium research and diagnosis

Share to Mycobacterium tuberculosis

Share to Pyrazinamide

Share to Tuberculosis Research and Epidemiology

Source

Open in PubMed Open full text

Identifiers

PMID: 11641519
DOI: 10.3346/jkms.2001.16.5.537
PMCID: PMC3057581

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.PMID 11641519Read ↗

Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.Semantic proximity Read ↗

Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, ChinaSemantic proximity Read ↗

Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium TuberculosisSemantic proximity Read ↗

Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China.Semantic proximity Read ↗

Characteristics of pncA mutations in multidrug-resistant tuberculosis in TaiwanSemantic proximity Read ↗

Genetic and phenotypic characterization of pyrazinamide-resistant mycobacterium tuberculosis complex isolates in Japan.Semantic proximity Read ↗

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.Semantic proximity Read ↗

Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.Semantic proximity Read ↗

Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.Semantic proximity Read ↗

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.Semantic proximity Read ↗

Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China.Semantic proximity Read ↗

Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.